Brian J Wilkinson
	
					    												
Tanzania						                            
                            
						
 Research Article
												 Novel Antibacterial Polypeptide Laparaxin Produced by Lactobacillus paracasei Strain NRRL B-50314 Via Fermentation 
												
Author(s): Siqing Liu, Brian J Wilkinson, Kenneth M Bischoff, Stephen R Hughes, Joseph O Rich and Michael A CottaSiqing Liu, Brian J Wilkinson, Kenneth M Bischoff, Stephen R Hughes, Joseph O Rich and Michael A Cotta             
						
												
				 This study reports the production and characterization of a novel antibacterial polypeptide, designated laparaxin, which is secreted by Lactobacillus paracasei NRRL B-50314. Crude laparaxin has antibacterial activity against a wide variety of Gram-positive bacteria, including: lactic acid bacteria (Lactococcus lactis and Lactobacillus buchneri), food-borne pathogens (Listeria monocytogenes), gastrointestinal pathogens (Enterococcus faecalis), and opportunistic pathogens (Staphylococcus aureus methicillin-sensitive (MSSA) and methicillin resistant (MRSA) strains, a hetero-vancomycin-intermediate methicillin resistant strain (Hetero VISA also MRSA) MM66, and homogeneous vancomycin intermediate (Homo VISA). Using L. lactis as an indicator strain, the inhibitory activity of crude laparaxin was detected originally in early log phase, and the activity maximizes at the early stationary phase.. View More»
				  
												DOI:
												 10.4172/2157-7463.1000121